Concepedia
Statistics
Publications
19
Citations
1.1K
H-Index
16
Active since
2013
Affiliations
University of Southampton(Current)
Southampton General Hospital
Cancer Research UK
University of Aberdeen
University of Liverpool
Lekh N. Dahal is an author at University of Southampton specializing in immunology, life sciences, and cancer immunotherapy.
Publications per year
2013–2023
Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function
Sarah L. Buchan, Lang Dou, Marcus Remer et al. · Immunity · 2018 · 153 citations · Full text
Life Sciences, Immunology, Oncology +14
The soluble isoform of CTLA‐4 as a regulator of T‐cell responses
Frank J. Ward, Lekh N. Dahal, Subadra K. Wijesekera et al. · European Journal of Immunology · 2013 · 135 citations
Life Sciences, Immunology, Molecular Biology +17
Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo
Ali Roghanian, Ingrid Teige, Linda Mårtensson et al. · Cancer Cell · 2015 · 133 citations · Full text
Pharmacy, Immunology, Oncology +14
Complex Interplay between Epitope Specificity and Isotype Dictates the Biological Activity of Anti-human CD40 Antibodies
Xiaojie Yu, H.T. Claude Chan, Christian M. Orr et al. · Cancer Cell · 2018 · 111 citations · Full text
Pharmacy, Immunology, Pharmacology +17
Antigenic modulation limits the effector cell mechanisms employed by type I anti-CD20 monoclonal antibodies
Thomas Tipton, Ali Roghanian, Robert Oldham et al. · Blood · 2015 · 82 citations · Full text
Life Sciences, Immunology, Pharmacology +17
1–5 of 19